RANTES Production from Mononuclear Cells in Response to the Specific Allergen in Asthma Patients  by Oyamada, Hajime et al.
RANTES Production from
Mononuclear Cells in Response to the
Specific Allergen in Asthma Patients
Hajime Oyamada1, Yumiko Kamada1, Norihiro Saito1, Akira Tsuda1, Osamu Urayama1,
Hidekazu Yamada2, Hiroyuki Hirasawa1, Kazutoshi Yamaguchi1, Shigeharu Ueki1 and Junichi Chi-
hara1
ABSTRACT
Background: Eosinophils are considered to be the major inflammatory cells in asthma. Since regulated on
activation, normal T expressed and secreted (RANTES) is a potent chemoattractant for various important in-
flammatory cells such as eosinophils as well as memory T cells potentially recruiting these cells to an inflamed
focus, RANTES has been considered to play a key role in various allergic disorders such as asthma.
Methods: To extend our understanding of the participation of eosinophils and T cells in relation to the produc-
tion of RANTES in response to the specific allergen in asthma, we examined the production of RANTES from
peripheral blood mononuclear cells cultured with specific allergen in atopic asthma patients by a sandwich
enzyme-linked immunosorbent assay.
Results: It was revealed that mononuclear cells produced RANTES but not eotaxin in response to the specific
allergen in asthma. RANTES production from mononuclear cells of asthma patients with eosinophilia was
greater than that of asthma patients without eosinophilia. Moreover, in this study, no differences in RANTES
production between CD4 negative cells and CD8 negative cells were observed.
Conclusions: Taken together, these findings may suggest that mononuclear cells play a crucial role in the
pathogenesis, particular in eosinophil and T lymphocyte recruitment into the inflamed focus of asthma through
RANTES production in response to the specific allergen.
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INTRODUCTION
Much attention has recently been focused on the in-
flammatory reaction in diseases such as asthma .
Eosinophils, together with T lymphocytes, are con-
sidered to be the major inflammatory cells in
asthma,1-6 since eosinophil specific granule proteins
can damage bronchial mucosa cells resulting in bron-
chial hyperreactivity.7 Mononuclear cells (MNC) and
platelets also have been implicated as important cells
in the inflammatory reactions, since they are an ex-
cellent source of a wide range of biologically active
materials of relevance to the inflammatory process.8-
10
Recently , the members of the chemokine family
are 8 ― 10 kD basic heparin-binding polypeptides
which are related in primary structure, in particular
being characterized by the presence of a four-
cysteine motif.11 Chemokines related to the beta sub-
family, the so called C-C branch of platelet factor 4
(PF4)-related proteins12 have been shown to stimu-
late human eosinophils or basophils, and are consid-
ered important mediators of inflammation . 11-13 Par-
ticularly, not only eotaxin but also RANTES has been
considered to play an important role in various im-
mune and allergic disorders,14,15 since RANTES is a
potent chemoattractant for various important inflam-
matory cells such as eosinophils16 as well as memory
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Fig. 1 Level of RANTES in the supernatant of PBMNC 
from patients (Patients) or controls (Control) cultured with 
( ) or without ( ) specific (mite) alergen. PBMNC were 
suspended at the concentration of 2×106/mL in RPMI1640 
with 10% heat-inactivated fetal calf serum and antibiotics. 
The cels were cultured in the presence or absence of mite-
alergen at 37 ℃ in 5% CO2 for 4 days (approximately for 84 
hours) and then the supernatants were obtained. RANTES 
in the supernatant of PBMNC was measured by ELISA.
 ＊＊ P＜0.01, significant diferences between with or without 
specific antigen.
Subjects
1000
2000
control Patients
R
A
N
T
E
S
 (
pg
/m
L)
＊＊
＊＊
0
T cells and monocytes,17 potentially recruiting these
cells from the circulation to an inflamed focus. There-
fore, it is of great interest to study the source of RAN-
TES production.
In this study, we examined the production of RAN-
TES and eotaxin from peripheral blood mononuclear
cells (PBMNC), cultured with specific allergen in pa-
tients with allergic asthma by a sandwich enzyme-
linked immunosorbent assay (ELISA).
METHODS
SUBJECTS
Twelve normal control subjects (19―58 years old, av-
erage age of 39.2 years) and 18 patients with bron-
chial asthma during attack as defined by the Ameri-
can Thoracic Society18 (16―61 years old, average age
of 37.4 years) were involved in this study. All patients
with asthma had mite-allergic asthma with an IgE
RAST score for mite allergen of 3 or more with posi-
tive skin test.
PBMNC ISOLATION AND ISOLATION OF CD4
OR CD8 NEGATIVE PBMNC
PBMNC were collected from the heparinized periph-
eral venous blood of patients with mite-allergic
asthma and that of normal control subjects, by Ficoll-
Paque (Pharmacia, Uppsala, Sweden) centrifugation.
PBMNC isolated as described above were sus-
pended in 2.0 mL of HBSS, anti-CD4 monoclonal anti-
body conjugated magnetic beads (Dynabeads, Dynal,
Norway ) were added at the proportion of 1 : 40
(MNC ; anti-CD 4 monoclonal antibody conjugated
magnetic beads), and the mixture was incubated for
45 minutes at 4℃ . These PBMNC that attached to
the magnetic beads were subsequently reacted with a
magnetic particle concentrator (MPC, Dynal , Nor-
way) for 15 minutes, and then CD4 positive cells were
removed to isolate the CD4 negative PBMNC. CD8
negative PBMNC were also isolated in the same man-
ner, using anti-CD8 monoclonal antibody conjugated
magnetic beads. Before being used for the experi-
ments , the isolated CD4 and CD8 negative MNC
were confirmed to contain <5% CD4 and CD8 positive
MNC, respectively, by the indirect fluorescent anti-
body technique and a FACScan (Becton-Dickinson,
Mountain View, CA, USA) as described elsewhere.10,
19
CELL CULTURE AND ELISA ASSAY FOR RAN-
TES
Cells were suspended at the concentration of 2 × 106
mL in RPMI1640 (GIBCO, Grand Island, NY, USA)
with 10% heat-inactivated fetal calf serum (FCS) (M.
A. Biproducts, MD, USA) and antibiotics (100 μgmL
penicillin and 100 μgmL streptomycin).19 Mite aller-
gen, which was the mite extract Dermatophagoides fa-
rinae (Torii Pharmaceutical Co, Tokyo, Japan), was
added at a final concentration of 10 μgmL as previ-
ously described . 19 The cells were cultured in the
presence or absence of mite-allergen at 37℃ in 5%
CO2 for 4 days (approximately for 84 hours) and then
the supernatants were obtained as described previ-
ously.10-19
RANTES in the supernatant of PBMNC was meas-
ured by ELISA as previously reported.20 In brief, an
ELISA kit (R & D systems, USA) with two antibodies
to differentiate epitopes of RANTES was used for the
assay. A 96-well plate was treated with anti-RANTES
monoclonal antibody, and 100 μl of the standard solu-
tion or the test sample was added followed by 50 μl of
horseradish peroxidase-labeled anti-RANTES anti-
body. Absorbance was determined at 450540 nm
with a Titertek Multiskan MCC340 spectrophotome-
ter (ICN, Labosystem Oy., Helsinki, Finland). A cali-
bration curve was generated with the standard solu-
tion, and the RANTES concentration in each sample
was determined from this curve (sensitivity 15.6 pg
ml or more). All determinations were performed in
duplicate or triplicate.
The level of β-thromboglobulin (β-TG) in superna-
tants was assessed according to a method described
in a previous study.21
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Fig. 2 The time course experiments of RANTES in the su-
pernatant from PBMNC of the patients cultured in the pres-
ence (  ) or absence (  ) of mite-alergen. PBMNC were 
suspended at the concentration of 2×106/mL in RPMI1640 
with 10% heat-inactivated fetal calf serum and antibiotics. 
The cels were cultured in the presence or absence of mite-
alergen at 37℃ in 5% CO2 for 3 hours, 24 hours, 48 hours, 
or 84 hours and then the supernatants were obtained. RAN-
TES in the supernatant of PBMNC was measured by ELISA. 
＊＊ P＜0.01, vs absence of mite-alergen.
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Fig. 3 RT-PCR analysis of RANTES mRNA expression in 
peripheral mononuclear cels. The amplified products were 
separated on 12.5% polyacrylamide gel, and the gel was 
subjected to silver staining. Lane 1: PBMNC from alergic pa-
tient cultured without mite-alergen; Lane 2: PBMNC from al-
lergic patient cultured with mite-alergen; Lane 3: human 
bronchial epithelial cel line (NCI-H292); Lane 4: negative 
control.
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Table 1 Time course of RANTES production from PBMNC
RANTES in the supernatant (pg/mL)b)
Culture conditionsa)Subjects Culture Duration
84 hrs48 hrs24 hrs3 hrs
593.00＊＊565.73＊＊558.75537.00
without mite
Patients
(n＝4)
± 112.33 ± 79.39 ± 96.53± 101.41
2014.50＊＊1079.75＊＊677.50580.00
with mite
± 229.59 ± 212.48 ± 129.70± 88.48
100.13 112.20 115.20102.00
without mite
Controls
(n＝4)
± 14.11 ± 10.75 ± 13.57± 9.15
124.60 120.98 139.70132.38
with mite
± 12.06 ± 14.19 ± 27.48± 22.64
a) PBMNC were suspended at the concentration of 2×106/mL in RPMI1640 (GIBCO, Grand Island, NY) with 10% heat-inactivated fetal 
calf serum and antibiotics. The cels were cultured in the presence or absence of mite-alergen at 37℃ in 5% CO2 for 3 hrs, 24 hrs, 48 hrs 
or 84 hrs and then the supernatant were obtained.
b) RANTES in the supernatants of PBMNC was measured by ELISA.
＊＊P＜0.01, significant diferences between with or without mite antigen.
PRIMERS
The RANTES primers used were 5 ’ primer , 5 ’
CTGTCATCCTCATTGCTACT ; and 3 ’ primer , 5 ’
ATCTCCAAAGAGTTGATGTAC ( product size 244
bp) . The eotaxin primers used were 5 ’ primer , 5 ’
GAAAGCTGTGATCTTCAAGAC; and 3 ’ primer , 5 ’
CATGCCCTTTGGACTGATAATGA ( product size
224 bp). As a control, G3PDH primers were used
(Clontech Co., USA).
REVERSE TRANSCRIPTION-POLYMERASE
CHAIN REACTION
Messenger RNA was isolated by the guanidinium
thiocyanate method (QuickPrep Micro mRNA Purifi-
cation kit, Pharmacia). A cDNA template for the po-
lymerase chain reaction (PCR) was prepared by re-
verse transcription using mRNA and distilled water
as negative control, Moloney murine leukemia virus
( M-MuLV ) reverse transcriptase , and random
hexadeoxy-nucleotides (First-Strand cDNA product
Synthesis kit; Pharmacia).
Six percent of each cDNA product was transferred
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Fig. 4 A comparison of RANTES production of PBMNC 
between CD4 negative and CD8 negative PBMNC. CD4 
negative or CD8 negative PBMNC were also isolated by 
magnetic isolation, using CD4 or CD8 conjugated magnetic 
beads. CD4 negative or CD8 negative PBMNC were sus-
pended at the concentration of 2×106/mL in RPMI1640 with 
10% heat-inactivated fetal calf serum and antibiotics. The 
cels were cultured in the presence of mite-alergen at 37 ℃ 
in 5% CO2 for 4 days and then the supernatants were 
obtained. RANTES in the supernatants of PBMNC was 
measured by ELISA.
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Fig. 5 Level of RANTES production from PBMNC of 
asthma patients with or without peripheral blood eosino-
philia (more than 8%) cultured with ( ) or without ( ) mite-
alergen. The cels were cultured in the presence or absence 
of mite-alergen at 37℃ in 5% CO2 for 4 days and then the 
supernatants were obtained. RANTES in the supernatant of 
PBMNC was measured by ELISA. ＊ P＜0.05 and ＊＊ P＜
0.01, vs between with or without mite-antigen.
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to individual tubes to which were added one of the 22
5’ -oligonucleotide primers, 30 pmol, and a reaction
mixture containing water , buffer , 10 mmol .l , de-
oxynucleotide triphosphates , and Ampli-TaqR DNA
polymerase (Perkin-Elmer). The reaction was carried
out with a Perkin-Elmer Gene-Amp PCR system 9600.
The PCR was started with an initial 45-second denatu-
ration step at 94℃, followed by 35 cycles of 94℃ de-
naturation for 10 seconds, annealing at 60℃ for 10
seconds, extension for 10 seconds at 72℃, with a final
extension step of 10 minutes at 72℃. The amplified
products were separated on 12.5% polyacrylamide
gels (PhastGel , Parmacia ) stained with the silver
staining method (PhastGel DNA Silver Staining kit,
Pharmacia).22
STATISTICAL ANALYSIS
Data were expressed as means ± SEM. Student’s t
test was used for comparison of means, and a P value
of 0.05 or less was considered to indicate a significant
difference.
RESULTS
LEVEL OF RANTES IN THE SUPERNATANT OF
PBMNC CULTURED WITHOUT SPECIFIC AL-
LERGEN (MITE-ALLERGEN)
The RANTES level of the supernatants of PBMNC
cultured without mite-allergen in patients with mite-
allergic asthma was 709.54 ± 171.74 pgmL (mean ±
SEM ) , while that in the control was 141.83 ±
22.92 pgmL. The RANTES level in the patients was
significantly higher than that in the controls in the
culture condition without mite allergen (P < 0.01, Fig.
1), whereas eotaxin was not detectable in any super-
natant (data not shown).
RANTES PRODUCTION FROM PBMNC IN RE-
SPONSE TO SPECIFIC ALLERGEN
In the culture condition with mite-allergen, the RAN-
TES level in the supernatant of PBMNC cultured with
mite-allergen in the patients was 1464.61 ± 218.87 pg
mL, whereas that in the controls was 152.81 ± 22.18
pgmL. The RANTES level in the patients was signifi-
cantly higher than that in the culture without mite al-
lergen in the same patients (P < 0.01) and than in that
the controls cultured with or without mite-allergen
(P < 0.01, Fig. 1) , there being no significant differ-
ences between the controls cultured with mite aller-
gen and without mite allergen ( 152.81 ± 22.18 vs
141.83 ± 22.92, P > 0.1, Fig. 1).
Moreover, in the time course experiments, RAN-
TES production from PBMNC in response to the spe-
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cific allergen was significantly observed in the culture
for 48 hours (Table 1, Fig. 2, P < 0.01).
In addition, gene (mRNA) expression for RANTES
was observed in PBMNC cultured with mite-allergen,
whereas eotaxin mRNA was not observed (Fig. 3).
To clarify the contamination of platelets , since
platelets are an excellent source of RANTES,15,17,21 β-
TG was also examined. In the culture condition with
mite-allergen, the β-TG level in the patients showed
no significant difference with that in the control
(118.6 ± 30.1 IUmL vs 122.8 ± 32.6 IUmL, P > 0.1).
COMPARISON OF RANTES PRODUCTION BE-
TWEEN CD4 NEGATIVE AND CD8 NEGATIVE
PBMNC
A comparative study on RANTES production between
CD4 negative and CD8 negative PBMNC in response
to mite allergen revealed no significant differences
(CD4 negative : 1359.67 ± 230.76 vs CD8 negative :
1317.00 ± 221.84, P > 0.1, Fig. 4)
A COMPARATIVE STUDY ON RANTES PRODUC-
TION FROM ASTHMATIC PATIENTS WITH PE-
RIPHERAL BLOOD EOSINOPHILIA AND WITH-
OUT EOSINOPHILIA
The level of RANTES production from PBMNC of pa-
tients with asthma with peripheral blood eosinophilia
(more than 8%) cultured without mite-allergen were
998.3 ± 268.54 (n = 10) pgmL, while that from those
without eosinophilia was 377.01 ± 77.68 (n = 8) pg
mL. The levels in the patients with eosinophilia were
significantly higher than those in the patients without
eosinophilia (P < 0.05, Fig. 5) in the culture condition
without specific allergen. Moreover, in response to
the specific allergen, the level of RANTES production
in the patients with eosinophilia was much more
higher than that in the patients without eosinophilia
(2014.20 ± 268.42 pgmL (n = 10) vs 777.63 ± 156.86
pgmL, n = 8, P < 0.01, Fig. 5 ).
DISCUSSION
Together with lymphocytes, eosinophils prominently
infiltrate in the bronchial mucosa of patients with
asthma, and are thought to be the cause of epithelial
damage and characteristic airway hyperreactiv-
ity. 4,5,23,24 Several stimuli have been implicated in
their recruitment and recent studies suggest that
lymphocytes of the Th2 type, which migrate together
with eosinophils into sites of late-phase reactions,25
are an important source of chemoattractant cytokines
and growth factors that prime eosinophils.26,27
RANTES is a member of the 8-kD cytokine family
that has been shown to possess selective chemotactic
activity for eosinophils . 17 Since RANTES attracts T
lymphocytes of the memory type (CD45RO+)15 be-
sides eosinophils , RANTES may be a common
mechanism in various allergic or immunological reac-
tions.28-34 The allergen-induced late phase airway re-
action in atopic subjects, in which both memory T
cell infiltration and eosinophil accumulation are char-
acteristic , 25,35 might represent a possible clinical
model.
In this context, it is of great interest to clarify the
source of RANTES production as well as eotaxin.34
RANTES originally was identified as an apparently T
cell-specific inducible gene, which was initially found
to be expressed by cultured T cell lines that were an-
tigen specific and growth factor dependent . 36 The
present findings revealed that MNC could produce
RANTES but not eotaxin in response to a specific al-
lergen in asthma patients . Our present results of
RANTES production from MNC of patients agree
with a previous report of a murine model.37 Eotaxin is
also one of the most important chemokines . How-
ever, it may not be generated by MNC but by cytoki-
nes such as IL-4 produced from MNC.38 We also ex-
amined the β-TG level to clarify the possible contami-
nation by platelets, since they are an excellent source
of RANTES.15 No significant differences in β-TG lev-
els were observed.
Moreover, in the present time course study, the
RANTES production from MNC in response to the
specific allergen was also revealed to apparently be
observed after 48 hours. However, RANTES release
from MNC without allergen in patients with asthma
was elevated as compared with that of controls with
or without mites, suggesting that the PBMNC of pa-
tients may have been stimulated in vivo. These find-
ings suggest that RANTES plays a key role in the air-
way inflammation in the late asthmatic response in
which eosinophilia is characterized.25,35 Indeed, RAN-
TES production from PBMNC of asthma patients
with eosinophilia was greater than that of patients
without eosinophilia.
Moreover, in this study, no significant differences
in RANTES production between CD4 negative cells
and CD8 negative cells were observed, in contrast
with the role of CD4 positive cells in IL-5 production
as we previously reported.39
While it was reported that RANTES was produced
predominantly by CD8+ as compared with CD4+, 40
our present results suggest, as one of several possi-
ble explanations, that not only CD8 positive cells but
also CD4 positive cells may be together involved in
the production of RANTES or that PBMNC which are
neither for CD4 nor for CD8 such as monocytes
macrophages may be involved. Indeed, expression of
RANTES was initially considered to be T-cell spe-
cific. 36 However , subsequent studies have revealed
that RANTES can be expressed by a broad range of
cell types such as synovial fibroblasts,41 monocytes
macrophages42,43 and platelets.17
Taken together, these findings suggest that MNC
play a crucial role in the pathogenesis, in particular in
eosinophil and T lymphocyte recruitment into the in-
flamed focus of asthma through RANTES production
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in response to specific allergen. The details of the
mechanism of production of RANTES from MNC in
the pathogenesis of bronchial asthma need to be fur-
ther investigated.
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